ABSTRACT
Hypertensive crises is still a major public health problem, causing end organ damage like myocardial infarction, stroke, and renal failure. Labetalol and nitroglycerine are among the two most commonly used medicine to control the blood pressure, but there is no head to head comparison between these two medicines. This was a prospective randomized non-blinded study which included 50 patients of hypertensive crises, out which 25 patients received intravenous labetalol and 25 patients received intravenous nitroglycerine. We found that labetalol controlled the blood pressure more rapidly in comparison to nitroglycerine, without causing any extra side effect
ABSTRACT
Currently, the whole world is facing a life-threatening novel coronavirus 2019 (COVID-19) pandemic. Natural products are well-known for their potential role against viral disease, and some anti-viral agents have been developed to combat these diseases. Herein, the authors investigated the possible effects of this Holy plant Nigella sativa L. (NS), against coronavirus, using evidence-based and mechanistic approaches to conclude the immune-boosting and alleviation of respiratory systemeffects of NS. The pharmacological studies established a prominent role in treating various respiratory, immune systems, cardiovascular, skin, and gastrointestinal disorders. Literature supported the significant anti-viral role and showed an inhibitory role for NS against MHV-A59 CoV (mouse-hepatitis virusA59) infected Hela, i.e., HeLaCEACAM1a (HeLa-epithelial carcinoembryonic antigen-related cell adhesion molecule 1a) cell. NS is a safe herbal product or dietary supplement and could be an effective and affordable community adjuvant treatment for coronavirus in the current scenario.
Actualmente, el mundo entero se enfrenta a una pandemia del nuevo coronavirus 2019 (COVID-19) que amenaza la vida. Los productos naturales son bien conocidos por su papel potencial contra las enfermedades virales, y se han desarrollado algunos agentes antivirales para combatir estas enfermedades. En este documento, los autores investigaron los posibles efectos de esta planta sagrada Nigella sativa L. (NS), contra el coronavirus, utilizando enfoques mecanicistas y basados en la evidencia para concluir el refuerzo inmunológico y el alivio de los efectos del SN en el sistema respiratorio. Los estudios farmacológicos establecieron un papel destacado en el tratamiento de diversos trastornos respiratorios, del sistema inmunológico, cardiovasculares, cutáneos y gastrointestinales. La literatura apoyó el importante papel antivírico y mostró un papel inhibidor de NS contra células Hela infectadas con MHV-A59 CoV (virus de la hepatitis de ratón-A59), es decir, HeLaCEACAM1a (molécula de adhesión celular 1a relacionada con el antígeno carcinoembrionario epitelial de HeLa). NS es un producto a base de hierbas o un suplemento dietético seguro y podría ser un tratamiento adyuvante comunitario eficaz y asequible para el coronavirus en el escenario actual.
Subject(s)
Humans , Antiviral Agents/pharmacology , Plant Extracts/pharmacology , Nigella sativa/chemistry , COVID-19/drug therapy , Antiviral Agents/immunology , Respiratory System/drug effects , Respiratory System/immunology , Plant Extracts/immunology , Anti-Asthmatic Agents , COVID-19/immunology , Immune System/drug effectsABSTRACT
Abstract The present study was designed to evaluate the beneficial synergistic effects of S-allyl Cysteine (SAC) and Taurine (TAU) on hyperglycemia, lipid profile and renal damage markers in type 2 diabetes mellitus (T2DM) in rats. Experimental T2DM was developed by administering an intraperitoneal single dose of nicotinamide (NA; 230 mg/kg) and streptozotocin (STZ; 65 mg/ kg) in adult rats. Control and diabetic rats were treated with SAC (150 mg/kg); TAU (200 mg/ kg) or SAC and TAU (75+100 mg/kg) combination for four weeks. Measurements of traditional markers of kidney toxicity in serum, such as blood urea nitrogen (BUN), serum creatinine (Scr), and alkaline phosphatase (ALP), together with serum cholesterol/triglyceride such as serum total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C) may yield a snapshot of renal damage and lipid profile in NA/STZ-treated rats. The variation in levels of fasting blood glucose, glycosylated hemoglobin, insulin and lipid profile was significantly augmented in SAC/TAU treatment group. The diabetic group showed elevated renal injury markers in serum, which were decreased significantly by SAC/TAU treatment. Thus the results of the experiment clearly indicate the potential of the SAC/TAU combination in improving diabetic complications.
ABSTRACT
This review present Gingko biloba (GB) interactions, based on clinical and pre-clinical presentations. Literature was retrieved using databases; ScienceDirect, PubMed, Google scholar, Web of Science, Scopus etc. 14/45 interactions were found with clinical presentations. More interactions (80%) were reported with drugs followed by herbs (11.1%), and nutraceuticals (6.7%) with major mechanisms of interaction observed as; inhibition of Cytochrome metabolizing enzymes (44.4%) and platelet-activating factor (PAF) i.e. 15.6%. Major clinical features were; increased bleeding (eye, parietal), hematomas (subdural), and seizures as well as increased blood pressure, priapism, loss of infection/antiviral failure, and coma. Drugs with major interactions belonged to anti-platelet/anti-coagulant and NSAIDs. Synergistic effects were observed for GB vs herbs (except cannabis which showed rhabdomyolysis), foods, and nutraceuticals (except pyridoxine where neurotoxicity was seen). GB use should be monitored and the patient may seek proper advice from a healthcare professional.
Esta revisión presenta las interacciones de Gingko biloba (GB), basadas en presentaciones clínicas y preclínicas. La literatura se recuperó utilizando bases de datos; ScienceDirect, PubMed, Google Scholar, Web of Science, Scopus, etc. Se encontraron 14/45 interacciones con presentaciones clínicas. Se informaron más interacciones (80%) con fármacos seguidos de hierbas (11,1%) y nutracéuticos (6,7%) con los principales mecanismos de interacción observados como; inhibición de las enzimas metabolizadoras del citocromo (44,4%) y factor activador de plaquetas (PAF), es decir, 15,6%. Las principales características clínicas fueron; aumento de sangrado (ojo, parietal), hematomas (subdural) y convulsiones, así como aumento de la presión arterial, priapismo, pérdida de infección / insuficiencia antiviral y coma. Los fármacos con interacciones importantes pertenecían a los antiplaquetarios/anticoagulantes y los AINE. Se observaron efectos sinérgicos para GB frente a hierbas (excepto cannabis que mostró rabdomiólisis), alimentos y nutracéuticos (excepto piridoxina donde se observó neurotoxicidad). Se debe controlar el uso de GB y el paciente puede buscar el asesoramiento adecuado de un profesional de la salud.
Subject(s)
Plant Extracts/pharmacokinetics , Ginkgo biloba , Herb-Drug Interactions/physiology , Plant Extracts/adverse effects , Dietary SupplementsABSTRACT
Background: Homeopathy, as an alternative treatment system for the treatment of various diseases, is widely used in various regions of the world. However the clinical benefits of homeopathy remains controversial. Aim of the Study: This review highlights the most up-to-date and current clinical trials and research carried out in the field of homeopathy and to compare its effectiveness in combating various diseases. Methodology: A retrospective literature search was performed from 2012 to 2017. All the articles, containing clinical trials in human subjects, were searched in different databases such as google scholar, science direct, web of science, Scopus, Springer Link and Sci Finder etc. using the keywords i.e. clinical trials in homeopathy, current clinical status of homeopathy, homeopathy and treatment of diseases, clinical cases in homeopathy and clinical studies in homeopathy. Results: Twenty one articles met the inclusion criteria and were included in this review. The results of these clinical studies showed an effective outcome for homeopathy treatment in various diseases such as atopic dermatitis, eczema, respiratory tract infections, asthma, hay fever and pulmonary tuberculosis etc. However, for some of the diseases such as depression, mental fatigue, cancer, HIV, anxiety, dementia, induction of labor, osteoarthritis, migraine and insomnia etc. no proper clinical evidence for a safe and effective use of homeopathy exists. Furthermore, the research quality of most the homeopathy clinical trials are objectionable and negatively analyzed by various authors in terms of sample size, reproducibility and replication of data as well as lack of proper guidelines for performing homeopathy research. Conclusion: To build credibility in health care system and attract more patients as well as professional practitioners towards this system of alternative treatment, more focus in terms of quality research and practically applicable clinical trials i.e. efficacy trials (near to optimal laboratory conditions) is needed.
ABSTRACT
Objective: To search for the most active antimicrobial and antioxidant sub-fractions related to traditional use of Ziziphus oxyphylla (Z. oxyphylla) and Cedrela serrata (C. serrata) in Pakistan against infectious and liver diseases. Methods: Factions of different polarity were tested in vitro for their antiprotozoal, antimalarial, antibacterial and antifungal activity against different pathogens. Cytotoxicity on MRC-5 cell lines (human lung fibroblasts) as well as, in vitro radical scavenging activity was evaluated using the 1, 1-diphenyl-2-picrylhydrazyl radical assay. Results: The highest antiprotozoal activity was observed for the CHCl3 fractions of Z. oxyphylla roots and leaves, and C. serrata bark. The CHCl3 and EtOAc fractions of Z. oxyphylla roots, the CHCl3 fraction of Z. oxyphylla leaves, the EtOAc and the residual MeOH: H2O fraction of C. serrata bark showed antibacterial activity against Staphylo-coccus aureus. The same residual MeOH: H2O fraction of C. serrata bark was active against Candida albicans. The highest antioxidant activity was observed for the more hydrophilic EtOAc fractions of Z. oxyphylla leaves, C. serrata bark and leaves, and the residual MeOH:H2O fraction of C. serrata bark. Conclusions: This study supports at least in part the traditional uses of these plants for antimicrobial purposes and against liver diseases.
ABSTRACT
Objective of the present study was to carry out the physicochemical and phytochemicals standardization of Lepidium sativum Lseeds to establish the standard pharmacognostical parameters of this valuable medicinal plant. Many standardization parameters of Lepidium sativum were analyzed. Standard method was adopted for the preliminary phytochemicals screening. Analysis of pesticides residues, aflatoxin & heavy metals were also performed. The sections of seeds were prepared for quantitative microscopic parameters. The air dried powdered plant material was subjected for determination of physicochemical standardizations like ash value, Extractive value and fluorescence nature of the powder drug using light of short and longwavelength of 254nm and 366nm respectively. Phytochemical screening was performed for the identification of phytoconstituents in the plant which was helpful in the development of analytical profile. The morphological and microscopic examinations of drug were revealed the presence of endosperm cell which are polygonal in shape and contain alerone grains and oil droplet, cell of testa, yellow colouring matter and starch grains. Preliminary phytochemical screening showed the presence of carbohydrates, phenolic compounds, flavonoids, alkaloids, proteins, saponins and lipids in the drug extract and flourescence nature of drug was confirmed by fluorescence analysis in different solvent. Concentrations of heavy metals,ash value and extractive value were determined and found within acceptable Pharmacopoeial limits. Pesticides residues and aflatoxins were also determined but not detected in the tested samples. The physicochemical and phytochemical standards which are outcome of this research may be utilized as substantial data for identification and standardization of L. sativum seed.
ABSTRACT
Objective of the present study was to carry out the physicochemical and phytochemicals standardization of Lepidium sativum L seeds to establish the standard pharmacognostical parameters of this valuable medicinal plant. Many standardization parameters of Lepidium sativum were analyzed. Standard method was adopted for the preliminary phytochemicals screening. Analysis of pesticides residues, aflatoxin & heavy metals were also performed. The sections of seeds were prepared for quantitative microscopic parameters. The air dried powdered plant material was subjected for determination of physicochemical standardizations like ash value, Extractive value and fluorescence nature of the powder drug using light of short and long wavelength of 254nm and 366nm respectively. Phytochemical screening was performed for the identification of phytoconstituents in the plant which was helpful in the development of analytical profile. The morphological and microscopic examinations of drug were revealed the presence of endosperm cell which are polygonal in shape and contain alerone grains and oil droplet, cell of testa, yellow colouring matter and starch grains. Preliminary phytochemical screening showed the presence of carbohydrates, phenolic compounds, flavonoids, alkaloids, proteins, saponins and lipids in the drug extract and flourescence nature of drug was confirmed by fluorescence analysis in different solvent. Concentrations of heavy metals,ash value and extractive value were determined and found within acceptable Pharmacopoeial limits. Pesticides residues and aflatoxins were also determined but not detected in the tested samples. The physicochemical and phytochemical standards which are outcome of this research may be utilized as substantial data for identifica-tion and standardization of L. sativum seed.
ABSTRACT
Aims: To determine the antioxidant, antiglycation and antibacterial activity of two selected plants found wild in Pakistan (Ziziphus oxyphylla and Cedrela serrata). Study Design: In vitro assessment of antioxidant assays, phenolic and flavonoid content, protein-glycation inhibition and antibacterial study. Place and Duration of Study: Department of Pharmaceutical Sciences, University of Antwerp Belgium (February - April 2013; Antioxidant, Protein glycation). Department of Pharmacognosy, University of Karachi, Pakistan (March – June, 2012; antibacterial). Methodology: In vitro laboratory experimental tests; preparation of plant extracts, antioxidant assays (ABTS.+, PMS-NADH radicals), total phenol, total flavonoid; protein glycation (fluorescence); susceptibility tests (zones of inhibition). Results: The bark of C. serrata contained the highest amount of total phenol (0.35 ± 0.04 mg GAE/g extract) and exhibited significantly superior ABTS.+ and PMS superoxide radical scavenging activity with IC50 values of 0.043 ± 0.001 mg/ml and 0.18 ± 0.01 mg/ml, respectively (P=0.05). Similarly, the protein-glycation assay revealed that the bark of C. serrata had the best inhibitory property with a low IC50 value of 0.61 ± 0.02 mg/ml (P=0.05), probably due to the presence of high amounts of total phenol. Furthermore, the various extracts showed considerable inhibition against both Gram–positive and – negative bacterial growth when compared against two standard drugs neomycin and doxycycline. Conclusion: The results of this study substantiate a probable role for these plants to be utilized as a natural source of antioxidant having a wide range of bioactivities.